$OPTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OPTIMER PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OPTIMER PHARMACEUTICALS INC. Get notifications about new insider transactions in OPTIMER PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Schaum Meredith | Gen Counsel and Chi ... | Option Exercise | D | 10.72 | 30,000 | 321,600 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Schaum Meredith | Gen Counsel and Chi ... | Sell | D | 10.75 | 2,937 | 31,573 | 0 | 2.9 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Sirota Eric | Chief Operating Off ... | Buy | D | 10.75 | 10,000 | 107,500 | 0 | -10,000 to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Sirota Eric | Chief Operating Off ... | Sell | D | 10.75 | 2,129 | 22,887 | 0 | 2.1 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AMPER LINDA E | SVP, Human Resource ... | Option Exercise | D | 10.72 | 30,000 | 321,600 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AMPER LINDA E | SVP, Human Resource ... | Option Exercise | D | 11.41 | 100,000 | 1,141,000 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | D | 10.72 | 60,000 | 643,200 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Webster Stephen W | Chief Financial Off ... | Sell | D | 10.75 | 16,666 | 179,160 | 0 | 16.7 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Webster Stephen W | Chief Financial Off ... | Sell | D | 10.75 | 8,334 | 89,591 | 16,666 | 25 K to 16.7 K (-33.34 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Option Exercise | D | 10.72 | 60,000 | 643,200 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Option Exercise | D | 11.41 | 40,000 | 456,400 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Option Exercise | D | 9.03 | 20,000 | 180,600 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Option Exercise | D | 11.85 | 12,000 | 142,200 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Option Exercise | D | 6.59 | 100,000 | 659,000 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Option Exercise | D | 6.90 | 7,500 | 51,750 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Option Exercise | D | 1.08 | 11,610 | 12,539 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Option Exercise | D | 1.08 | 1,298 | 1,402 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Sell | D | 10.75 | 2,333 | 25,080 | 0 | 2.3 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Scientif ... | Sell | D | 10.75 | 39,886 | 428,775 | 2,333 | 42.2 K to 2.3 K (-94.47 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | CEO and Chairman of ... | Option Exercise | D | 10.72 | 225,000 | 2,412,000 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | CEO and Chairman of ... | Option Exercise | D | 11.67 | 10,000 | 116,700 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | CEO and Chairman of ... | Option Exercise | D | 11.67 | 20,000 | 233,400 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | CEO and Chairman of ... | Sell | D | 10.75 | 10,000 | 107,500 | 0 | 10 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | CEO and Chairman of ... | Sell | D | 10.75 | 15,000 | 161,250 | 10,000 | 25 K to 10 K (-60.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | CEO and Chairman of ... | Buy | D | 10.75 | 10,000 | 107,500 | 25,000 | 15 K to 25 K (+66.67 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Newman Stephen L | Director | Sell | D | 10.75 | 7,500 | 80,625 | 0 | 7.5 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Option Exercise | D | 9.56 | 10,000 | 95,600 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Option Exercise | D | 11.85 | 10,000 | 118,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Option Exercise | D | 11.85 | 10,000 | 118,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Option Exercise | D | 10.85 | 5,000 | 54,250 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Option Exercise | D | 10.85 | 10,000 | 108,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Sell | D | 10.75 | 7,500 | 80,625 | 0 | 7.5 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Sell | D | 10.75 | 7,500 | 80,625 | 7,500 | 15 K to 7.5 K (-50.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Option Exercise | D | 9.56 | 10,000 | 95,600 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Option Exercise | D | 11.85 | 10,000 | 118,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Option Exercise | D | 11.85 | 10,000 | 118,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Option Exercise | D | 10.90 | 10,000 | 109,000 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Sell | D | 10.75 | 7,500 | 80,625 | 0 | 7.5 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Sell | D | 10.75 | 7,500 | 80,625 | 7,500 | 15 K to 7.5 K (-50.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Option Exercise | D | 9.56 | 10,000 | 95,600 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Option Exercise | D | 11.85 | 10,000 | 118,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Option Exercise | D | 10.75 | 5,000 | 53,750 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Option Exercise | D | 7.10 | 5,000 | 35,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Option Exercise | D | 2.17 | 3,461 | 7,510 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Sell | D | 10.75 | 10,000 | 107,500 | 0 | 10 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Sell | D | 10.75 | 10,000 | 107,500 | 10,000 | 20 K to 10 K (-50.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | D | 11.41 | 11,000 | 125,510 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | D | 11.85 | 30,000 | 355,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | D | 9.56 | 2,000 | 19,120 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | D | 11.85 | 80,000 | 948,000 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | D | 10.75 | 80,000 | 860,000 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Sell | D | 10.75 | 441,761 | 4,748,931 | 0 | 441.8 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Sell | D | 10.75 | 1,026,956 | 11,039,777 | 0 | 1 M to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | D | 9.56 | 10,000 | 95,600 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | D | 11.85 | 10,000 | 118,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | D | 10.75 | 5,000 | 53,750 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | D | 7.10 | 5,000 | 35,500 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | D | 2.17 | 3,461 | 7,510 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | D | 2.17 | 3,461 | 7,510 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | D | 1.08 | 3,461 | 3,738 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | D | 1.08 | 3,461 | 3,738 | 0 | |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Sell | D | 10.75 | 46,154 | 496,156 | 0 | 46.2 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Sell | D | 10.75 | 7,500 | 80,625 | 0 | 7.5 K to 0 (-100.00 %) |
Oct 28 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Sell | D | 10.75 | 10,000 | 107,500 | 7,500 | 17.5 K to 7.5 K (-57.14 %) |
Oct 25 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Option Exercise | D | 9.56 | 10,000 | 95,600 | 0 | |
Oct 25 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Option Exercise | D | 11.85 | 10,000 | 118,500 | 0 | |
Oct 25 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Option Exercise | D | 10.75 | 5,000 | 53,750 | 0 | |
Oct 25 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Option Exercise | D | 7.10 | 10,000 | 71,000 | 0 | |
Oct 25 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Option Exercise | D | 7.10 | 5,000 | 35,500 | 0 | |
Oct 25 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Sell | D | 10.75 | 7,500 | 80,625 | 0 | 7.5 K to 0 (-100.00 %) |
Oct 25 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Sell | D | 10.75 | 7,500 | 80,625 | 7,500 | 15 K to 7.5 K (-50.00 %) |
Oct 25 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Sell | D | 10.75 | 5,000 | 53,750 | 15,000 | 20 K to 15 K (-25.00 %) |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 11.41 | 9,000 | 102,690 | 11,000 | |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 10.75 | 30,000 | 322,500 | 0 | |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 6.90 | 30,000 | 207,000 | 0 | |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 9.70 | 30,000 | 291,000 | 0 | |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 2.17 | 4,615 | 10,015 | 0 | |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 9.56 | 8,000 | 76,480 | 2,000 | |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 6.90 | 70,000 | 483,000 | 0 | |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 9.70 | 100,000 | 970,000 | 0 | |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 11.41 | 9,000 | 102,690 | 441,761 | 432.8 K to 441.8 K (+2.08 %) |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 10.75 | 30,000 | 322,500 | 432,761 | 402.8 K to 432.8 K (+7.45 %) |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 6.90 | 30,000 | 207,000 | 402,761 | 372.8 K to 402.8 K (+8.05 %) |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 9.70 | 30,000 | 291,000 | 372,761 | 342.8 K to 372.8 K (+8.75 %) |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 2.17 | 4,615 | 10,015 | 342,761 | 338.1 K to 342.8 K (+1.36 %) |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 9.56 | 8,000 | 76,480 | 1,026,956 | 1 M to 1 M (+0.79 %) |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 6.90 | 70,000 | 483,000 | 1,018,956 | 949 K to 1 M (+7.38 %) |
Sep 06 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 9.70 | 100,000 | 970,000 | 948,956 | 849 K to 949 K (+11.78 %) |
May 17 2013 | OPTR | OPTIMER PHARMACEUT ... | Schaum Meredith | Gen.Counsel and Chi ... | Buy | J | 7.53 | 1,789 | 13,473 | 1,789 | 0 to 1.8 K |
Apr 25 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 1.08 | 117,263 | 127,043 | 0 | |
Apr 25 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 1.08 | 117,263 | 127,043 | 848,956 | 731.7 K to 849 K (+16.03 %) |
May 13 2013 | OPTR | OPTIMER PHARMACEUT ... | Sirota Eric | Chief Operating Off ... | Grant | A | 0.00 | 10,000 | 0 | 12,129 | 2.1 K to 12.1 K (+469.70 %) |
Apr 11 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 12.34 | 18,750 | 231,375 | 0 | |
Apr 11 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 12.34 | 84,375 | 1,041,188 | 0 | |
Apr 11 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 12.34 | 103,125 | 1,272,563 | 731,693 | 628.6 K to 731.7 K (+16.41 %) |
Apr 10 2013 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | Option Exercise | M | 13.51 | 90,000 | 1,215,900 | 0 | ||
Apr 10 2013 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | Option Exercise | M | 11.41 | 58,000 | 661,780 | 0 | ||
Apr 10 2013 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | Sell | S | 14.73 | 90,000 | 1,325,538 | 104,078 | 194.1 K to 104.1 K (-46.37 %) | |
Apr 10 2013 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | Sell | S | 14.63 | 58,000 | 848,453 | 194,078 | 252.1 K to 194.1 K (-23.01 %) | |
Apr 10 2013 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | Buy | M | 13.51 | 90,000 | 1,215,900 | 252,078 | 162.1 K to 252.1 K (+55.53 %) | |
Apr 10 2013 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | Buy | M | 11.41 | 58,000 | 661,780 | 162,078 | 104.1 K to 162.1 K (+55.73 %) | |
Apr 05 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 12.34 | 103,125 | 1,272,563 | 0 | |
Apr 05 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Option Exercise | M | 12.34 | 42,187 | 520,588 | 0 | |
Apr 05 2013 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Buy | M | 12.34 | 145,312 | 1,793,150 | 628,568 | 483.3 K to 628.6 K (+30.07 %) |
Mar 01 2013 | OPTR | OPTIMER PHARMACEUT ... | Schaum Meredith | Gen. Counsel,Chief ... | Option Exercise | A | 10.72 | 30,000 | 321,600 | 30,000 | |
Feb 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AMPER LINDA E | SVP, Human Resource ... | Option Exercise | A | 10.72 | 30,000 | 321,600 | 30,000 | |
Feb 28 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Grant | A | 0.00 | 2,500 | 0 | 20,000 | 17.5 K to 20 K (+14.29 %) |
Feb 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | Chief Scientific Of ... | Option Exercise | A | 10.72 | 60,000 | 643,200 | 60,000 | |
Feb 28 2013 | OPTR | OPTIMER PHARMACEUT ... | Webster Stephen W | CFO | Option Exercise | A | 10.72 | 60,000 | 643,200 | 60,000 | |
Feb 28 2013 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | CEO and Chairman of ... | Option Exercise | A | 10.72 | 225,000 | 2,412,000 | 225,000 | |
Jan 03 2013 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Grant | A | 0.00 | 7,500 | 0 | 15,000 | 7.5 K to 15 K (+100.00 %) |
Jan 03 2013 | OPTR | OPTIMER PHARMACEUT ... | Newman Stephen L | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Jan 03 2013 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | Director | Grant | A | 0.00 | 10,000 | 0 | 35,000 | 25 K to 35 K (+40.00 %) |
Jan 03 2013 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Grant | A | 0.00 | 7,500 | 0 | 15,000 | 7.5 K to 15 K (+100.00 %) |
Jan 03 2013 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Grant | A | 0.00 | 7,500 | 0 | 109,806 | 102.3 K to 109.8 K (+7.33 %) |
Jan 03 2013 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Grant | A | 0.00 | 7,500 | 0 | 17,500 | 10 K to 17.5 K (+75.00 %) |
Jan 03 2013 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Grant | A | 0.00 | 7,500 | 0 | 20,000 | 12.5 K to 20 K (+60.00 %) |
Nov 19 2012 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | CEO and President | Buy | P | 9.08 | 11,000 | 99,847 | 104,078 | 93.1 K to 104.1 K (+11.82 %) |
Aug 14 2012 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | Chief Scientific Of ... | Grant | A | 0.00 | 3,500 | 0 | 42,219 | 38.7 K to 42.2 K (+9.04 %) |
Aug 14 2012 | OPTR | OPTIMER PHARMACEUT ... | Hartman Kurt M | General Counsel, SV ... | Grant | A | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
Jul 24 2012 | OPTR | OPTIMER PHARMACEUT ... | Newman Stephen L | Director | Option Exercise | A | 14.01 | 20,000 | 280,200 | 20,000 | |
Jul 02 2012 | OPTR | OPTIMER PHARMACEUT ... | Webster Stephen W | CFO | Option Exercise | A | 15.46 | 100,000 | 1,546,000 | 100,000 | |
Jul 02 2012 | OPTR | OPTIMER PHARMACEUT ... | Webster Stephen W | CFO | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jun 25 2012 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
Jun 20 2012 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Option Exercise | M | 0.65 | 3,461 | 2,250 | 0 | |
Jun 20 2012 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Sell | S | 15.30 | 3,461 | 52,953 | 102,306 | 105.8 K to 102.3 K (-3.27 %) |
Jun 20 2012 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Buy | M | 0.65 | 3,461 | 2,250 | 105,767 | 102.3 K to 105.8 K (+3.38 %) |
Jun 20 2012 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Grant | A | 0.00 | 2,500 | 0 | 102,306 | 99.8 K to 102.3 K (+2.50 %) |
Jun 20 2012 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | Director | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
Jun 20 2012 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
Jun 20 2012 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
May 17 2012 | OPTR | OPTIMER PHARMACEUT ... | Papaz Gregory E. | SVP, Commercial Ope ... | Buy | J | 9.72 | 998 | 9,705 | 2,592 | 1.6 K to 2.6 K (+62.61 %) |
Jun 20 2012 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
May 17 2012 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Medical ... | Buy | J | 9.72 | 531 | 5,163 | 38,719 | 38.2 K to 38.7 K (+1.39 %) |
May 17 2012 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | CEO and President | Buy | J | 9.72 | 2,185 | 21,247 | 93,078 | 90.9 K to 93.1 K (+2.40 %) |
Feb 09 2012 | OPTR | OPTIMER PHARMACEUT ... | Papaz Gregory E. | SVP, Commercial Ope ... | Option Exercise | A | 13.51 | 18,750 | 253,313 | 18,750 | |
Feb 09 2012 | OPTR | OPTIMER PHARMACEUT ... | Shue Youe Kong | VP, Clinical Develo ... | Option Exercise | A | 13.51 | 4,000 | 54,040 | 4,000 | |
Feb 09 2012 | OPTR | OPTIMER PHARMACEUT ... | Hartman Kurt M | Gen. Counsel, Chief ... | Option Exercise | A | 13.51 | 18,750 | 253,313 | 18,750 | |
Feb 09 2012 | OPTR | OPTIMER PHARMACEUT ... | Gorbach MD Sherwood | SVP, Chief Medical ... | Option Exercise | A | 13.51 | 24,320 | 328,563 | 24,320 | |
Feb 09 2012 | OPTR | OPTIMER PHARMACEUT ... | AMPER LINDA E | SVP, Human Resource ... | Option Exercise | A | 13.51 | 18,750 | 253,313 | 18,750 | |
Feb 09 2012 | OPTR | OPTIMER PHARMACEUT ... | LICHTINGER PEDRO | CEO and President | Option Exercise | A | 13.51 | 120,000 | 1,621,200 | 120,000 | |
Jan 03 2012 | OPTR | OPTIMER PHARMACEUT ... | MCKINNELL HENRY A | Director | Grant | A | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
Feb 09 2012 | OPTR | OPTIMER PHARMACEUT ... | Prunty John D | CFO and SVP, Financ ... | Option Exercise | A | 13.51 | 35,000 | 472,850 | 35,000 | |
Jan 03 2012 | OPTR | OPTIMER PHARMACEUT ... | GREBOW PETER E | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jan 03 2012 | OPTR | OPTIMER PHARMACEUT ... | ZERBE ROBERT L MD | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jan 03 2012 | OPTR | OPTIMER PHARMACEUT ... | AUERBACH MARK | Director | Grant | A | 0.00 | 5,000 | 0 | 7,500 | 2.5 K to 7.5 K (+200.00 %) |
Jan 03 2012 | OPTR | OPTIMER PHARMACEUT ... | ALTIG ANTHONY E | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Jan 03 2012 | OPTR | OPTIMER PHARMACEUT ... | CHANG JOSEPH Y | Director | Grant | A | 0.00 | 5,000 | 0 | 99,806 | 94.8 K to 99.8 K (+5.27 %) |
Jan 03 2012 | OPTR | OPTIMER PHARMACEUT ... | Che Tessie M | COO and SVP | Grant | A | 0.00 | 5,000 | 0 | 483,256 | 478.3 K to 483.3 K (+1.05 %) |
Jan 03 2012 | OPTR | OPTIMER PHARMACEUT ... | Chang Michael N | Director | Grant | A | 0.00 | 5,000 | 0 | 483,256 | 478.3 K to 483.3 K (+1.05 %) |